What was JNJ's closing price?

JNJ closed at $244.88, up 1.61% from the previous session.

Is JNJ a safe investment during market volatility?

Yes, JNJ is considered a defensive stock due to its stable earnings and regular dividends, making it less affected by market swings.

Johnson & Johnson (JNJ) Rises 1.61% as Market Declines

Johnson & Johnson (JNJ) shares rose 1.61% to close at $244.88, bucking the broader market downturn. The move highlights the defensive appeal of healthcare stocks during market turbulence.

June 25, 2026

2 min read

Source: Zacks

Key Numbers

closing price

244.88

daily change pct

+1.61%

Johnson & Johnson (JNJ) shares advanced 1.61% in the latest trading session, closing at $244.88, outperforming a declining broader market. The gain underscores the defensive characteristics of healthcare stocks amid market uncertainty.

Possible Reasons

Defensive Nature: Healthcare stocks like JNJ are considered safe havens during economic uncertainty due to stable demand for their products.
Strong Fundamentals: Investors may be confident in JNJ's consistent financial performance, even without recent earnings reports.
Risk-Off Sentiment: During market declines, investors often rotate into low-volatility, dividend-paying stocks.

Context

Weekly Performance: JNJ has shown limited volatility compared to major indices, reflecting its stability.
Sector Performance: The healthcare sector broadly outperformed the market, with several stocks posting gains.

Similar Moves in the Sector

Other healthcare names like Pfizer (PFE) and Merck (MRK) also saw modest gains, confirming the sector's defensive rotation.

Frequently Asked Questions

The stock rose due to its defensive nature; investors flock to healthcare stocks during market downturns because demand for their products remains stable.

Found this useful? Share it

This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.